Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
EU Biotech Act Aims to Streamline European Clinical Trials
Management & Regulatory EU Biotech Act Aims to Streamline European Clinical Trials

The competitive gap between Europe and regions like the United States and China is widening due to administrative delays that slow the deployment of multinational clinical studies. While the European Union possesses world-class healthcare infrastructure, the logistical reality for biotech

Combining Viruses and CAR-T Therapy to Fight B-Cell Cancers
Research & Development Combining Viruses and CAR-T Therapy to Fight B-Cell Cancers

By inducing the lysis of malignant cells, oncolytic viruses release a broad spectrum of neoantigens that can prime a patient’s native immune system through a process called epitope spreading. This mechanism represents a significant shift from the current clinical standard of single-target Chimeric

How Can Biosecurity Distinguish Dissent From Misinformation?
Tech & Innovation How Can Biosecurity Distinguish Dissent From Misinformation?

The politicization of daily life during biological emergencies makes the governance of information as critical to safety as the distribution of essential medical supplies. In the contemporary landscape of 2026, the success of any public health intervention is no longer measured solely by laboratory

How Can We Close the Gap in Early Drug Discovery?
Research & Development How Can We Close the Gap in Early Drug Discovery?

The ability of a compound to cross cell membranes and reach intracellular targets is a critical variable that simple test-tube assays cannot measure. This fundamental reality underscores the massive disconnect currently plaguing the pharmaceutical industry, where high-potency molecules identified

Namibia Unveils First Public MRI to Boost Healthcare Equity
Management & Regulatory Namibia Unveils First Public MRI to Boost Healthcare Equity

The high cost of referring more than 4,000 state patients to private facilities for imaging services has historically drained approximately 16 million Namibian dollars from the public budget every year. This financial burden often meant that essential funds were diverted from other critical areas,

Can 40°C Optimize Growth for Avian Cultivated Protein?
Biotech & Bioprocessing Can 40°C Optimize Growth for Avian Cultivated Protein?

While 37 degrees Celsius is the global default for biological research, it may actually induce a state of chronic metabolic sluggishness in chicken muscle cells. The emergence of cellular agriculture marks a pivotal shift in how the world approaches food security and sustainable protein, yet the

Mexico Mandates Nationwide Digital Health Integration by 2026
Management & Regulatory Mexico Mandates Nationwide Digital Health Integration by 2026

The success of the 2026 mandate hinges on the ability of rural clinics to access the same high-quality digital history as specialized private hospitals in Mexico City. By fundamentally altering the General Health Law, the federal government has declared digital health a matter of absolute public

Veradigm Breach Highlights Growing Healthcare Cyber Risks
Tech & Innovation Veradigm Breach Highlights Growing Healthcare Cyber Risks

Security experts are tracking an alarming trend of cyberattacks targeting third-party vendors like Veradigm to compromise the broader healthcare infrastructure. As healthcare systems increasingly outsource critical functions ranging from electronic health records management to predictive analytics,

DSC-BSite Revolutionizes Protein Binding Site Prediction
Tech & Innovation DSC-BSite Revolutionizes Protein Binding Site Prediction

The traditional labor-intensive process of utilizing high-resolution imaging and biochemical assays to map binding sites often spans several years. This bottleneck has long hindered the pace of pharmaceutical innovation, forcing researchers to rely on trial-and-error methods that consume vast

Can a Digital Assistant Improve Insulin Infusion Safety?
Tech & Innovation Can a Digital Assistant Improve Insulin Infusion Safety?

Validation studies reveal that manual insulin calculations performed by nursing staff matched expert standards in only thirty-five out of one hundred and twenty cases. This startling discrepancy highlights the immense pressure and risk inherent in managing intravenous insulin infusions within

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later